Cryosite
1999
FOUNDED
PUBLIC
STATUS
21-30
EMPLOYEES
CTE
STOCK SYMBOL
1
INVESTMENTS
$0.04
SHARE PRICE
(As of Friday Closing)
Description
Cryosite Ltd is incorporated and domiciled in Australia. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.
Primary Industry
Biotechnology
Stock Exchange
ASX
Primary Office
- 13a Ferndell Street South
- Granville, New South Wales 2142
- Australia
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cryosite’s full profile, request a free trial.
Cryosite Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.02 - $0.04 | $1.73M | $0.03 | 87.3K | 46.9M |
Cryosite Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2019
30-Jun-2019
|
FY 2018
30-Jun-2018
|
FY 2017
30-Jun-2017
|
|---|---|---|---|---|
| Enterprise Value | (1,353) | (1,353) | (304) | 1,851 |
| Revenue | 5,657 | 5,657 | 4,542 | 7,230 |
| EBITDA | (56) | (56) | 349 | 643 |
| Net Income | (404) | (404) | (961) | 170 |
| Total Assets | 16,228 | 16,228 | 5,688 | 7,552 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Cryosite Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 01-Dec-2016 | 000000000000000000 | Other Healthcare Services |